Associate Professor
Duke University
Dr. Susanna Naggie completed her medical education at Johns Hopkins School of Medicine and her internal medicine training at Duke University Medical Center (DUMC), where she also served as a Chief Resident in Internal Medicine. She completed her Infectious Diseases (ID) fellowship training at Duke and then joined the faculty in the Division of ID. She is an Associate Professor of Medicine with Tenure and currently holds joint appointments at the Duke Clinical Research Institute (DCRI, Director of ID Research), and at the Durham Veterans Affairs Medical Center (DVAMC). Dr. Naggie has dedicated her academic career to the care of patients with HIV and viral hepatitis, with a research program focused on understanding the mechanisms of accelerated liver fibrogenesis in this population and the extrahepatic health outcomes attributed to HCV in persons with HIV infection. In addition to her investigator-initiated research program, Dr. Naggie is also involved in multiple clinical trials and clinical registries with a particular focus on HIV and liver disease. She is the prior co-Chair of the AASLD/IDSA HCV Guidance Committee and is currently Chair of the AIDS Clinical Trials Group Viral Hepatitis Transformative Science Group Committee and a member of the DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline Committee.
Disclosure: Abbvie: Grant/Research Support; BioMarin: Consultant; FHI360: Consultant; Gilead Sciences: Grant/Research Support; PRA: Consultant; Tacere: Grant/Research Support; Theratechnologies Inc (Individual(s) Involved: Self): Advisor or Review Panel member; Vir Biotechnology: Consultant
Thursday, October 22, 2020
12:30pm – 1:45pm EDT
Friday, October 23, 2020
10:00am – 11:15am EDT
Friday, October 23, 2020
2:45pm – 4:00pm EDT
